C. Robert Horsburgh, MD

Professor, Epidemiology

C. Horsburgh
617.358.3758
715 Albany St Talbot Building

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.

Other Positions

  • Professor, Global Health, Boston University School of Public Health
  • Professor, Infectious Diseases, Medicine, Boston University School of Medicine
  • Professor, Biostatistics, Boston University School of Public Health
  • Boston Medical Center

Websites

    Education

    • Case Western Reserve University, MD
    • Yale University, MS
    • Princeton University, AB

    Publications

    • Published on 4/1/2018

      Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):413-416. PMID: 29206723.

      Read at: PubMed
    • Published on 4/1/2018

      Dheda K, Gumbo T, Lange C, Horsburgh CR, Furin J. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 Apr; 6(4):240-242. PMID: 29595502.

      Read at: PubMed
    • Published on 1/31/2018

      Leong S, Zhao Y, Joseph NM, Hochberg NS, Sarkar S, Pleskunas J, Hom D, Lakshminarayanan S, Horsburgh CR, Roy G, Ellner JJ, Johnson WE, Salgame P. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India. Tuberculosis (Edinb). 2018 Mar; 109:41-51. PMID: 29559120.

      Read at: PubMed
    • Published on 1/18/2018

      Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 Jan 18; 66(3):376-384. PMID: 29020317.

      Read at: PubMed
    • Published on 12/1/2017

      Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model. JAMA Intern Med. 2017 Dec 01; 177(12):1755-1764. PMID: 29049814.

      Read at: PubMed
    • Published on 11/25/2017

      Bouton TC, Phillips PPJ, Mitnick CD, Peloquin CA, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Horsburgh CR. An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial. Trials. 2017 Nov 25; 18(1):563. PMID: 29178937.

      Read at: PubMed
    • Published on 8/23/2017

      Hochberg NS, Sarkar S, Horsburgh CR, Knudsen S, Pleskunas J, Sahu S, Kubiak RW, Govindarajan S, Salgame P, Lakshminarayanan S, Sivaprakasam A, White LF, Joseph NM, Ellner JJ, Roy G. Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention. PLoS One. 2017; 12(8):e0183195. PMID: 28832615.

      Read at: PubMed
    • Published on 8/15/2017

      Van Ness SE, Chandra A, Sarkar S, Pleskunas J, Ellner JJ, Roy G, Lakshminarayanan S, Sahu S, Horsburgh CR, Jenkins HE, Hochberg NS. Predictors of delayed care seeking for tuberculosis in southern India: an observational study. BMC Infect Dis. 2017 Aug 15; 17(1):567. PMID: 28806911.

      Read at: PubMed
    • Published on 5/3/2017

      Reddy D, Walker J, White LF, Brandeis GH, Russell ML, Horsburgh CR, Hochberg NS. Latent Tuberculosis Infection Testing Practices in Long-Term Care Facilities, Boston, Massachusetts. J Am Geriatr Soc. 2017 Jun; 65(6):1145-1151. PMID: 28467605.

      Read at: PubMed
    • Published on 3/31/2017

      Simonsen DF, Farkas DK, Horsburgh CR, Thomsen RW, Sørensen HT. Increased risk of active tuberculosis after cancer diagnosis. J Infect. 2017 Jun; 74(6):590-598. PMID: 28366685.

      Read at: PubMed

    View 190 more publications: View full profile at BUMC

    View all profiles